The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Shares have seen a slow but steady rise over the last few weeks. Anyone have an opinion for short term prospects. About to test a new high.
Was expecting a move upwards once Amazon started to sell and was tempted to buy back in when share price dropped below 2p. Share however in decline. Amazon won’t however be the determining factor, only large orders, which at present are not forthcoming, will be a game changer. Amazon price also not competitive with other 4y suppliers.
Having sold at 2.72p having made a healthy profit I may be tempted back in, if the share price falls below 2p to buy this week. I think the expectation of 10p may a little over optimistic. Back up to 3p might be more realistic if they can sort out their production and marketing problems. Need a more sales focused operation once production difficulties are resolved.
In my humble opinion this will not start to shift significantly until they get production under control and marketing sorted. The share will eventually be valued based upon their ability to show that they can generate revenue. For now the she’s a hold, but not one to add to until production and marketing sorted.
If Directors were selling it would have to be reported to the Authorities, no mention as yet, volumes traded are hardly voluminous, I have not so far noticed any major trades. The sells are probably from people panicking because the market is falling. You only have to look at what’s happening at RMS to see that herd mentality often spooks the market. I have invested in AIM shares over many years, if I had sold every time the market falls I would not have enjoyed the profits at a later date. Hold for better days.
You are so right about NCYT. On numerous occasions If I had listened to those who constantly forecast doom and gloom for NCYT I would have lost out on a substantial gain. I will hold BRH hoping for the same returns, it pays sometimes to ignore the constant chatter.
All those that think the horse has bolted are sadly mistaken. Just because the UK has got the vaccine role out sorted does not mean there will not be a need for mass testing for large sport, large indoor or other outdoor events. Also remember where the UK leads on vaccine, other Countries lag, international travel will not resume to previous levels until effective testing is in place. With other variants present this will not go away.
Took the opportunity to purchase a few more with a dividend received for another stock. Have tried to buy on the dips, not always successful. Don’t expect this to rise rapidly but will be pleased if it reaches 4p in the near future.